sapropterin teva 100 mg
teva gmbh - sapropterindihydroklorid - oppløselig tablett - 100 mg
champix
pfizer europe ma eeig - vareniklin - tobakk bruk stopp - andre nervesystemet narkotika - champix er indisert for røykeslutt hos voksne.
cefotaxim navamedic 0.5 g
navamedic asa - cefotaksimnatrium - pulver til injeksjonsvæske, oppløsning - 0.5 g
cefotaxim navamedic 1 g
navamedic asa - cefotaksimnatrium - pulver til injeksjonsvæske, oppløsning - 1 g
cefotaxim navamedic 2 g
navamedic asa - cefotaksimnatrium - pulver til injeksjonsvæske, oppløsning - 2 g
enalapril krka 5 mg
krka sverige ab - enalaprilmaleat - tablett - 5 mg
enalapril krka 10 mg
krka sverige ab - enalaprilmaleat - tablett - 10 mg
enalapril krka 20 mg
krka sverige ab - enalaprilmaleat - tablett - 20 mg
ferglep vet 200 mg/ ml
laboratories hipra s.a. - gleptoferron - injeksjonsvæske, oppløsning - 200 mg/ ml
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastiske midler - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.